MedPath

The effect of hydroxychloroquine to prevent coronavirus disease

Phase 3
Recruiting
Conditions
Covid-19.
COVID-19, Virus Identified
U07.1
Registration Number
IRCT20190122042450N4
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Clinical symptoms including: Fever
Shortness of breath
Cough
Positive Covide test
Typical symptoms on a CT scan

Exclusion Criteria

Hypersensitivity reaction to Hydroxychloroquine
Already taking Chloroquine or Hydroxychloroquine
Cardiac Arrhythmia
Already taking drugs that prolong QT
Decreased renal function in stages 4 and 5.(GFR <30)
The history of enzymatic disorders caused by some drugs that result in red blood cell lysis (G6PD).
The history of Retinopathy
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath